Valuation: EDAP TMS S.A.

Market Cap 193M 171M 160M 146M 275M 18.55B 278M 1.94B 751M 9.48B 725M 709M 30.44B P/E 2026 *
-3.71x
P/E 2027 * -5.47x
Enterprise Value 193M 171M 160M 146M 275M 18.55B 278M 1.94B 751M 9.48B 725M 709M 30.44B EV / Sales 2026 *
3.71x
EV / Sales 2027 * 2.77x
Free-Float
32.85%
Yield 2026 *
-
Yield 2027 * -
1 day-2.78%
1 week-10.83%
Current month-6.04%
1 month+0.72%
3 months-18.92%
6 months+23.89%
Current year+27.66%
1 week 4.16
Extreme 4.16
4.77
1 month 4
Extreme 4
4.77
Current year 3.1
Extreme 3.1
6.4
1 year 1.75
Extreme 1.75
6.4
3 years 1.21
Extreme 1.21
8.5
5 years 1.21
Extreme 1.21
12.65
10 years 1.21
Extreme 1.21
12.65
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2023
Director of Finance/CFO 55 31/12/2023
General Counsel 43 31/08/2025
Director TitleAgeSince
Director/Board Member 64 31/07/2023
Chairman 64 31/08/2024
Director/Board Member 62 07/07/2024
Date Insider Type Main position Quantity % Market Cap. Importance
14/08/26 Buy

Chief Financial Officer

5,000 0.0133%
14/08/26 Buy

Director

10,000 0.0267%
14/08/26 Buy

Chairman

50,000 0.1334%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-10.83%+81.03%-37.78% 193M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -0.70%-3.34%+6.17%+16.20% 82.28B
Weighted average by Cap. -0.29%-3.27%+1.09%+21.93%

Financials

2026 *2027 *
Net sales 52M 46.2M 43.12M 39.3M 74.12M 5B 74.81M 522M 202M 2.56B 195M 191M 8.2B 69.73M 61.95M 57.82M 52.7M 99.4M 6.7B 100M 700M 271M 3.43B 262M 256M 11B
Net income -47.66M -42.35M -39.52M -36.03M -67.94M -4.58B -68.58M -478M -185M -2.34B -179M -175M -7.52B -31.59M -28.07M -26.19M -23.88M -45.03M -3.04B -45.45M -317M -123M -1.55B -119M -116M -4.98B
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
289
Date Price Change Volume
02/10/26 US$4.200 -2.78% 52,913
01/10/26 US$4.320 -3.36% 124,398
30/09/26 US$4.470 -1.54% 94,961
29/09/26 US$4.540 +0.22% 65,024
28/09/26 US$4.530 -3.82% 116,469
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.200USD
Average target price
8.800USD
Spread / Average Target
+109.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FOCL Stock